- Home
- Automated
- List of product information
- TELFAST TABLET 180 MG [SIN11699P]
TELFAST TABLET 180 MG [SIN11699P]
Active ingredients: TELFAST TABLET 180 MG
Last updated 26 October 2025
Product Info
TELFAST TABLET 180 MG
[SIN11699P]
Product information
Active Ingredient and Strength | FEXOFENADINE HCL - 180 MG |
Dosage Form | TABLET, FILM COATED |
Manufacturer and Country | PT. KALVENTIS SINERGI FARMA - INDONESIA REP OF |
Registration Number | SIN11699P |
Licence Holder | OPELLA HEALTHCARE SINGAPORE PTE. LTD. |
Forensic Classification | PRESCRIPTION ONLY MEDICINES |
Anatomical Therapeutic Chemical (ATC) code | R06AX26 |
Indications
Telfast 180mg is indicated for the relief of symptoms associated with Seasonal Allergic Rhinitis (SAR) and Chronic Idiopathic Urticaria (CIU) in adults and children 12 years of age and older.
Dosage and method of administration
Adults and children aged 12 years and older
The recommended dose is one tablet once daily.
Special risk groups
Studies in special risk groups (elderly, renally or hepatically impaired patients) indicate that it is not necessary to adjust the dose of fexofenadine hydrochloride in these patients.
Contraindications
Fexofenadine is contraindicated in patients with known hypersensitivity to any of its ingredients.